CTHRC1 and metastatic melanoma: Using immunohistochemistry staining, Tang and Dai et al [17] found that CTHRC1 expression is absent in the benign nevi or noninvasive stages of melanoma (melanoma in situ) and dramatically increases in the invasive and metastatic melanoma.